vimarsana.com

Beijing released specific rules on experiments relating to COVID-19 and banned any activities that fall beyond regulatory approval, the capital's health authority said in a newly released notice, in a move to further strengthen COVID-19 laboratory biosafety.

Related Keywords

China ,Beijing , ,Municipal Health Commission ,National Health Commission ,China National Pharmaceutical Group Sinopharm ,Xinhua ,China National Pharmaceutical Group ,Beijing Municipal Health Commission ,Beijing Municipal Health ,Laboratory ,Health ,Strengthen ,Commission ,

© 2025 Vimarsana

vimarsana.com © 2020. All Rights Reserved.